{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T14:18:55Z","timestamp":1787494735805,"version":"build-2736575974"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res Treat"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1007\/s10549-020-05818-9","type":"journal-article","created":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T04:43:07Z","timestamp":1596256987000},"page":"11-21","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":38,"title":["Combined SOX10 GATA3 is most sensitive in detecting primary and metastatic breast cancers: a comparative study of breast markers in multiple tumors"],"prefix":"10.1007","volume":"184","author":[{"given":"Chaiwat","family":"Aphivatanasiri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shirley K.","family":"Jamidi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia Y.","family":"Tsang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivan K.","family":"Poon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Shao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanna","family":"Tong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ka-Fai","family":"To","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siu-Ki","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fiona","family":"Tam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sai-Yin","family":"Cheung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ka-Ho","family":"Shea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary M.","family":"Tse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,8,1]]},"reference":[{"issue":"7","key":"5818_CR1","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1016\/j.humpath.2012.10.009","volume":"44","author":"MH Luo","year":"2013","unstructured":"Luo MH, Huang YH, Ni YB, Tsang JY, Chan SK, Shao MM, Tse GM (2013) Expression of mammaglobin and gross cystic disease fluid protein-15 in breast carcinomas. Hum Pathol 44(7):1241\u20131250. https:\/\/doi.org\/10.1016\/j.humpath.2012.10.009","journal-title":"Hum Pathol"},{"issue":"3","key":"5818_CR2","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1097\/PAS.0000000000001216","volume":"43","author":"E Laurent","year":"2019","unstructured":"Laurent E, Begueret H, Bonhomme B, Veillon R, Thumerel M, Velasco V, Brouste V, Hoppe S, Fournier M, Grellety T, MacGrogan G (2019) SOX10, GATA3, GCDFP15, androgen receptor, and mammaglobin for the differential diagnosis between triple-negative breast cancer and TTF1-negative lung adenocarcinoma. Am J Surg Pathol 43(3):293\u2013302. https:\/\/doi.org\/10.1097\/PAS.0000000000001216","journal-title":"Am J Surg Pathol"},{"issue":"1","key":"5818_CR3","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1007\/s10549-017-4645-2","volume":"169","author":"YB Ni","year":"2018","unstructured":"Ni YB, Tsang JYS, Shao MM, Chan SK, Cheung SY, Tong J, To KF, Tse GM (2018) GATA-3 is superior to GCDFP-15 and mammaglobin to identify primary and metastatic breast cancer. Breast Cancer Res Treat 169(1):25\u201332. https:\/\/doi.org\/10.1007\/s10549-017-4645-2","journal-title":"Breast Cancer Res Treat"},{"issue":"11","key":"5818_CR4","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1136\/jclinpath-2016-204137","volume":"70","author":"T Shaoxian","year":"2017","unstructured":"Shaoxian T, Baohua Y, Xiaoli X, Yufan C, Xiaoyu T, Hongfen L, Rui B, Xiangjie S, Ruohong S, Wentao Y (2017) Characterisation of GATA3 expression in invasive breast cancer: differences in histological subtypes and immunohistochemically defined molecular subtypes. J Clin Pathol 70(11):926\u2013934. https:\/\/doi.org\/10.1136\/jclinpath-2016-204137","journal-title":"J Clin Pathol"},{"issue":"12","key":"5818_CR5","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.5858\/arpa.2014-0061-RA","volume":"138","author":"F Lin","year":"2014","unstructured":"Lin F, Liu H (2014) Immunohistochemistry in undifferentiated neoplasm\/tumor of uncertain origin. Arch Pathol Lab Med 138(12):1583\u20131610. https:\/\/doi.org\/10.5858\/arpa.2014-0061-RA","journal-title":"Arch Pathol Lab Med"},{"issue":"20","key":"5818_CR6","doi-asserted-by":"publisher","first-page":"3024","DOI":"10.1038\/sj.onc.1206442","volume":"22","author":"R Mollaaghababa","year":"2003","unstructured":"Mollaaghababa R, Pavan WJ (2003) The importance of having your SOX on: role of SOX10 in the development of neural crest-derived melanocytes and glia. Oncogene 22(20):3024\u20133034. https:\/\/doi.org\/10.1038\/sj.onc.1206442","journal-title":"Oncogene"},{"key":"5818_CR7","doi-asserted-by":"publisher","DOI":"10.1007\/s00428-019-02557-1","author":"K Chiu","year":"2019","unstructured":"Chiu K, Ionescu DN, Hayes M (2019) SOX10 expression in mammary invasive ductal carcinomas and benign breast tissue. Virchows Arch. https:\/\/doi.org\/10.1007\/s00428-019-02557-1","journal-title":"Virchows Arch"},{"issue":"6","key":"5818_CR8","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1016\/j.humpath.2012.09.005","volume":"44","author":"A Cimino-Mathews","year":"2013","unstructured":"Cimino-Mathews A, Subhawong AP, Elwood H, Warzecha HN, Sharma R, Park BH, Taube JM, Illei PB, Argani P (2013) Neural crest transcription factor Sox10 is preferentially expressed in triple-negative and metaplastic breast carcinomas. Hum Pathol 44(6):959\u2013965. https:\/\/doi.org\/10.1016\/j.humpath.2012.09.005","journal-title":"Hum Pathol"},{"issue":"6","key":"5818_CR9","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1097\/PAS.0000000000000398","volume":"39","author":"M Miettinen","year":"2015","unstructured":"Miettinen M, McCue PA, Sarlomo-Rikala M, Biernat W, Czapiewski P, Kopczynski J, Thompson LD, Lasota J, Wang Z, Fetsch JF (2015) Sox10\u2013a marker for not only schwannian and melanocytic neoplasms but also myoepithelial cell tumors of soft tissue: a systematic analysis of 5134 tumors. Am J Surg Pathol 39(6):826\u2013835. https:\/\/doi.org\/10.1097\/PAS.0000000000000398","journal-title":"Am J Surg Pathol"},{"key":"5818_CR10","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.humpath.2017.08.011","volume":"67","author":"ER Nelson","year":"2017","unstructured":"Nelson ER, Sharma R, Argani P, Cimino-Mathews A (2017) Utility of Sox10 labeling in metastatic breast carcinomas. Hum Pathol 67:205\u2013210. https:\/\/doi.org\/10.1016\/j.humpath.2017.08.011","journal-title":"Hum Pathol"},{"key":"5818_CR11","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.humpath.2018.06.007","volume":"80","author":"A Harbhajanka","year":"2018","unstructured":"Harbhajanka A, Chahar S, Miskimen K, Silverman P, Harris L, Williams N, Varadan V, Gilmore H (2018) Clinicopathological, immunohistochemical and molecular correlation of neural crest transcription factor SOX10 expression in triple-negative breast carcinoma. Hum Pathol 80:163\u2013169. https:\/\/doi.org\/10.1016\/j.humpath.2018.06.007","journal-title":"Hum Pathol"},{"key":"5818_CR12","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/j.humpath.2018.11.005","volume":"85","author":"GH Tozbikian","year":"2019","unstructured":"Tozbikian GH, Zynger DL (2019) A combination of GATA3 and SOX10 is useful for the diagnosis of metastatic triple-negative breast cancer. Hum Pathol 85:221\u2013227. https:\/\/doi.org\/10.1016\/j.humpath.2018.11.005","journal-title":"Hum Pathol"},{"issue":"Suppl 2","key":"5818_CR13","doi-asserted-by":"publisher","first-page":"S36","DOI":"10.1016\/j.breast.2015.07.009","volume":"24","author":"BD Lehmann","year":"2015","unstructured":"Lehmann BD, Pietenpol JA (2015) Clinical implications of molecular heterogeneity in triple negative breast cancer. Breast 24(Suppl 2):S36\u201340. https:\/\/doi.org\/10.1016\/j.breast.2015.07.009","journal-title":"Breast"},{"issue":"1","key":"5818_CR14","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1043\/1543-2165-134.1.130","volume":"134","author":"B Haupt","year":"2010","unstructured":"Haupt B, Ro JY, Schwartz MR (2010) Basal-like breast carcinoma: a phenotypically distinct entity. Arch Pathol Lab Med 134(1):130\u2013133. https:\/\/doi.org\/10.1043\/1543-2165-134.1.130","journal-title":"Arch Pathol Lab Med"},{"issue":"1","key":"5818_CR15","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1097\/PAS.0b013e3182a0218f","volume":"38","author":"M Miettinen","year":"2014","unstructured":"Miettinen M, McCue PA, Sarlomo-Rikala M, Rys J, Czapiewski P, Wazny K, Langfort R, Waloszczyk P, Biernat W, Lasota J, Wang Z (2014) GATA3: a multispecific but potentially useful marker in surgical pathology: a systematic analysis of 2500 epithelial and nonepithelial tumors. Am J Surg Pathol 38(1):13\u201322. https:\/\/doi.org\/10.1097\/PAS.0b013e3182a0218f","journal-title":"Am J Surg Pathol"},{"issue":"4","key":"5818_CR16","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1111\/his.12287","volume":"64","author":"YB Ni","year":"2014","unstructured":"Ni YB, Tsang JY, Shao MM, Chan SK, Tong J, To KF, Tse GM (2014) TTF-1 expression in breast carcinoma: an unusual but real phenomenon. Histopathology 64(4):504\u2013511. https:\/\/doi.org\/10.1111\/his.12287","journal-title":"Histopathology"},{"issue":"Suppl 2","key":"5818_CR17","doi-asserted-by":"publisher","first-page":"S41","DOI":"10.1038\/modpathol.3800516","volume":"19","author":"CM Magro","year":"2006","unstructured":"Magro CM, Crowson AN, Mihm MC (2006) Unusual variants of malignant melanoma. Mod Pathol 19(Suppl 2):S41\u201370. https:\/\/doi.org\/10.1038\/modpathol.3800516","journal-title":"Mod Pathol"},{"issue":"1","key":"5818_CR18","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1053\/j.semdp.2009.12.007","volume":"27","author":"MP Foschini","year":"2010","unstructured":"Foschini MP, Krausz T (2010) Salivary gland-type tumors of the breast: a spectrum of benign and malignant tumors including \"triple negative carcinomas\" of low malignant potential. Semin Diagn Pathol 27(1):77\u201390","journal-title":"Semin Diagn Pathol"},{"issue":"5","key":"5818_CR19","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1111\/cyt.12108","volume":"25","author":"P Alath","year":"2014","unstructured":"Alath P, Kapila K, Hussein S, Amanguno H, Hebbar HG, George SS, Francis IM (2014) Parotid gland metastasis of breast cancer diagnosed on fine needle aspiration cytology: case report and review of literature. Cytopathology 25(5):346\u2013348. https:\/\/doi.org\/10.1111\/cyt.12108","journal-title":"Cytopathology"},{"issue":"Suppl 1","key":"5818_CR20","doi-asserted-by":"publisher","first-page":"E2374","DOI":"10.1002\/hed.24344","volume":"38","author":"F Lopez","year":"2016","unstructured":"Lopez F, Rodrigo JP, Silver CE, Haigentz M Jr, Bishop JA, Strojan P, Hartl DM, Bradley PJ, Mendenhall WM, Suarez C, Takes RP, Hamoir M, Robbins KT, Shaha AR, Werner JA, Rinaldo A, Ferlito A (2016) Cervical lymph node metastases from remote primary tumor sites. Head Neck 38(Suppl 1):E2374\u20132385. https:\/\/doi.org\/10.1002\/hed.24344","journal-title":"Head Neck"}],"container-title":["Breast Cancer Research and Treatment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-020-05818-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10549-020-05818-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-020-05818-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,31]],"date-time":"2021-07-31T19:50:54Z","timestamp":1627761054000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10549-020-05818-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,1]]},"references-count":20,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,11]]}},"alternative-id":["5818"],"URL":"https:\/\/doi.org\/10.1007\/s10549-020-05818-9","relation":{},"ISSN":["0167-6806","1573-7217"],"issn-type":[{"value":"0167-6806","type":"print"},{"value":"1573-7217","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,1]]},"assertion":[{"value":"6 March 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 July 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 August 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"All authors have no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. The study was approved, including dispensation from the requirement of patient consent by Joint Chinese University of Hong Kong\u2014New Territories East Cluster clinical research ethics committee (2014.500).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The samples involved in the current study were retrieved from pathology tissue bank after used for diagnosis. All samples were irreversibly anonymized prior to inclusion of the study. Researchers were blinded from patient data during experimental and statistical procedure. Patient confidentiality has been protected and the study involved minimal risk to the subjects, Therefore, the requirement to obtain written consent has been waived.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}